ZEVRA THERAPEUTICS, INC. - COMMON STOCK (ZVRA)
CUSIP: 488445206
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 58,397,755
- Total 13F shares
- 35,351,805
- Share change
- +1,591,944
- Total reported value
- $264,779,873
- Put/Call ratio
- 322%
- Price per share
- $7.49
- Number of holders
- 109
- Value change
- +$11,437,756
- Number of buys
- 56
- Number of sells
- 40
Quarterly Holders Quick Answers
What is CUSIP 488445206?
CUSIP 488445206 identifies ZVRA - ZEVRA THERAPEUTICS, INC. - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 488445206:
Top shareholders of ZVRA - ZEVRA THERAPEUTICS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Woodline Partners LP |
13F
|
Company |
7.1%
|
4,139,593
|
$34,524,206 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.6%
from 13D/G
|
4,080,420
|
$34,030,703 | — | 31 Dec 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
6.3%
|
3,650,000
|
$30,441,000 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.8%
|
2,824,212
|
$23,553,927 | — | 31 Dec 2024 | |
| Nantahala Capital Management, LLC |
13F
13D/G
|
Company |
4.4%
from 13D/G
|
2,340,333
|
$19,518,377 | — | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
4%
|
2,329,343
|
$19,426,721 | — | 31 Dec 2024 | |
| Samuel J. Braun |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,153,000
|
$15,636,043 | — | 13 May 2021 | |
| Altium Capital Management LLC |
13F
|
Company |
3.2%
|
1,850,000
|
$15,429,000 | — | 31 Dec 2024 | |
| 683 Capital Management, LLC |
13F
|
Company |
2.1%
|
1,225,834
|
$10,223,455 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
1,188,120
|
$9,911,554 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
2%
|
1,172,556
|
$9,779,117 | — | 31 Dec 2024 | |
| J. Goldman & Co LP |
13F
|
Company |
1.5%
|
875,815
|
$7,304,297 | — | 31 Dec 2024 | |
| AIGH Capital Management LLC |
13F
|
Company |
1.4%
|
788,614
|
$6,577,041 | — | 31 Dec 2024 | |
| Rubric Capital Management LP |
13F
|
Company |
1.1%
|
616,123
|
$5,138,466 | — | 31 Dec 2024 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
1%
|
597,700
|
$4,984,818 | — | 31 Dec 2024 | |
| Retirement Planning Co of New England, Inc. |
13F
|
Company |
0.88%
|
514,832
|
$4,293,699 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.75%
|
435,972
|
$3,636,007 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.59%
|
343,818
|
$2,867,442 | — | 31 Dec 2024 | |
| Stratos Wealth Partners, LTD. |
13F
|
Company |
0.58%
|
335,840
|
$2,800,906 | — | 31 Dec 2024 | |
| Mystic Asset Management, Inc. |
13F
|
Company |
0.54%
|
313,347
|
$2,613,314 | — | 31 Dec 2024 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.51%
|
300,000
|
$2,502,000 | — | 31 Dec 2024 | |
| Janney Montgomery Scott LLC |
13F
|
Company |
0.51%
|
297,394
|
$2,480,000 | — | 31 Dec 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.5%
|
292,772
|
$2,441,719 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.5%
|
289,688
|
$2,415,998 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.44%
|
257,223
|
$2,145,239 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.43%
|
249,935
|
$2,084,458 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.4%
|
233,132
|
$1,944,321 | — | 31 Dec 2024 | |
| Propel Bio Management, LLC |
13F
|
Company |
0.31%
|
179,874
|
$1,500,149 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.26%
|
153,077
|
$1,276,662 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.26%
|
149,504
|
$1,246,863 | — | 31 Dec 2024 | |
| Kovack Advisors, Inc. |
13F
|
Company |
0.25%
|
146,158
|
$1,218,958 | — | 31 Dec 2024 | |
| Simplify Asset Management Inc. |
13F
|
Company |
0.21%
|
120,000
|
$1,000,800 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.19%
|
108,487
|
$904,778 | — | 31 Dec 2024 | |
| CREDIT AGRICOLE S A |
13F
|
Individual |
0.18%
|
106,000
|
$884,040 | — | 31 Dec 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.18%
|
104,630
|
$872,614 | — | 31 Dec 2024 | |
| Travis C. Mickle |
3/4/5
|
President & CEO, Director |
—
class O/S missing
|
171,774
|
$851,845 | — | 25 May 2022 | |
| LMR Partners LLP |
13F
|
Company |
0.17%
|
100,000
|
$834,000 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.17%
|
98,245
|
$819,363 | — | 31 Dec 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
85,818
|
$715,722 | — | 31 Dec 2024 | |
| Arete Wealth Advisors, LLC |
13F
|
Company |
0.13%
|
77,972
|
$649,000 | — | 31 Dec 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.12%
|
68,053
|
$567,550 | — | 31 Dec 2024 | |
| READYSTATE ASSET MANAGEMENT LP |
13F
|
Company |
0.11%
|
66,662
|
$555,961 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.09%
|
51,284
|
$427,709 | — | 31 Dec 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.09%
|
50,906
|
$424,556 | — | 31 Dec 2024 | |
| Sven Guenther |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
79,000
|
$391,769 | — | 31 Jan 2024 | |
| Christal M. M. Mickle |
3/4/5
|
Chief Development Officer |
—
class O/S missing
|
77,000
|
$381,851 | — | 31 Jan 2024 | |
| DIADEMA PARTNERS LP |
13F
|
Company |
0.07%
|
42,081
|
$350,956 | — | 31 Dec 2024 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.06%
|
32,802
|
$273,569 | — | 31 Dec 2024 | |
| STRS OHIO |
13F
|
Company |
0.06%
|
32,700
|
$272,718 | — | 31 Dec 2024 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.05%
|
30,427
|
$254,000 | — | 31 Dec 2024 |
Institutional Holders of ZEVRA THERAPEUTICS, INC. - COMMON STOCK (ZVRA) as of Q1 2025
As of 31 Mar 2025,
ZEVRA THERAPEUTICS, INC. - COMMON STOCK (ZVRA) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,351,805 shares.
The largest 10 holders included
Woodline Partners LP, BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, FMR LLC, Nantahala Capital Management, LLC, AIGH Capital Management LLC, Altium Capital Management LLC, GEODE CAPITAL MANAGEMENT, LLC, and 683 Capital Management, LLC.
This page lists
110
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
108
Q1 2025 holders
109
Holder diff
1
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.